Dr. rer. nat.
Member of the board, Chief Technology Officer
Dr. Noboru Yamazaki was elected at the 2013 Annual General Assembly to the Board of InnoMedica. His years of research experience in the field of active targeting and his solid experience in patent applications are key to the success of the InnoMedica oncology project.
He founded the company Yamazaki DDS Co., Ltd. to develop new applications with an active targeting drug delivery system. This new technology results from his research while working as group leader of the NanoBio-Medicine Technology Laboratory at the Nanotechnology Research Institute of the National Institute of Advanced Industrial Science and Technology (AIST) in Japan. Dr. Yamazaki worked with scientists from the Chemistry Department of the University of Colorado and the Max Planck Institute of Experimental Medicine and was director of research grants at the International Human Frontier Science Program Organization. After receiving his PhD in Biology from the University of Hamburg and postdoctoral research at Mitsubishi Kasei Institute of Life Sciences, Research Officer of the Industrial Products Research Institute, he began his career at AIST as Head of Materials Design Laboratory.
